ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for November 2018

2018 ASTRO Guideline for Palliative Thoracic Radiation Therapy for NSCLC: The Balance Between Curative and Palliative Radiotherapy

on: November 08, 2018In: Radiation Oncology
2018 ASTRO Guideline for Palliative Thoracic Radiation Therapy for NSCLC: The Balance Between Curative
            and Palliative Radiotherapy

By Shalini K. Vinod, MBBS, MD Posted: October 2018 The standard of care for patients with inoperable stage III NSCLC is curative radiotherapy and concurrent chemotherapy.1 However, there are numerous […] Read more


The Vital and Evolving Role of Bronchoscopic Technologies in Lung Cancer Management

on: November 08, 2018In: Evolving Standards of Care
The Vital and Evolving Role of Bronchoscopic Technologies in Lung Cancer Management

By Andrew R. Haas, MD, PhD Posted: October 2018 Lung cancer remains the leading global cause of cancer-related mortality.1 Due to the lack of symptoms at the time early-stage disease […] Read more

Living in the “Gray Zone”: Entering a New Age in Radiation Therapy for Patients with Lung Cancer

on: November 08, 2018In: Radiation Oncology
Living in the “Gray Zone”: Entering a New Age in Radiation Therapy for Patients with Lung
            Cancer

Posted: October 2018 Patients with stage III or more advanced lung cancer tend to be older and less healthy than patients with other stage III cancers. Because of this, selection […] Read more

Top Science in Lung Cancer Featured at WCLC 2018

on: November 08, 2018In: Meeting News
Top Science in Lung Cancer Featured at WCLC 2018

By Kara Nyberg, PhD Posted: October 2018 The Presidential Symposium at the IASLC World Conference on Lung Cancer 2018 (WCLC) showcased the top five scientific abstracts highlighting progress in detecting […] Read more

A Review of CancerSEEK

on: November 08, 2018In: Lung Cancer Risk Reduction & Prevention
A Review of CancerSEEK

By Pierre P. Massion, MD Posted: October 2018 Early detection is key to disease management. For example, there are numerous data in hypertension, diabetes, coronary artery disease, and renal dysfunction […] Read more

The IASLC Provides More Than Just Scientific Knowledge at Tangier Conference

on: November 08, 2018In: Global Initiatives
The IASLC Provides More Than Just Scientific Knowledge at Tangier Conference

By Anna Wrona, MD, PhD Posted: October 2018 The IASLC Africa Conference on Lung Cancer 2018 in Tangier, Morocco, held last spring, provided participants with unique expert perspectives in lung […] Read more

The Treatment of Patients with Oligometastatic Lung Cancer

on: November 08, 2018In: Evolving Standards of Care
The Treatment of Patients with Oligometastatic Lung Cancer

By Anne-Marie C. Dingemans, MD, PhD, and Lizza E.L. Hendriks, MD, PhD Posted: October 2018 Patients with stage IV NSCLC are generally viewed as having incurable disease; however, for years, […] Read more

CAR-T Cells for Lung Cancer: Q&A with Dr. Charu Aggarwal

on: November 08, 2018In: Evolving Standards of Care
CAR-T Cells for Lung Cancer: Q&A with Dr. Charu Aggarwal

Posted: October 2018 With complete remissions seen in up to 90% of patients with B-cell acute lymphoblastic leukemia (ALL), a breakthrough therapy designation in multiple myeloma, and a first-of-its-kind approval […] Read more

The IASLC Fight Against Lung Cancer in Peru and Latin America

on: November 08, 2018In: Uncategorized
The IASLC Fight Against Lung Cancer in Peru and Latin America

By Dr. Luis E. Raez, MD Posted: October 2018 Peru is one of the largest Latin American countries, with a population of approximately 28 million people. Cancer is not yet […] Read more

Antoinette Wozniak, MD

on: November 08, 2018In: Names & News
Antoinette Wozniak, MD

Posted: October 2018 Antoinette Wozniak, MD, moved to Hillman Cancer Center at University of Pittsburgh Medical Center in September 2018, where she is now a professor of medicine, leader of […] Read more

12

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy